Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter

Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter

There are scant data on the impact of coronavirus disease 2019 (COVID-19) on hospital antibiotic consumption, and no data from outside epicenters. At our nonepicenter hospital, antibiotic days of therapy (DOT) and bed days of care (BDOC) were reduced by 151.5/month and 285/month, respectively, for M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial agents and chemotherapy 2020-10, Vol.64 (11)
Hauptverfasser: Buehrle, Deanna J, Decker, Brooke K, Wagener, Marilyn M, Adalja, Amesh, Singh, Nina, McEllistrem, Mary C, Nguyen, M Hong, Clancy, Cornelius J
Format: Artikel
Sprache:eng
Schlagworte:
Anti-Bacterial Agents - therapeutic use
Antimicrobial Stewardship
Betacoronavirus - physiology
Clinical Therapeutics
Coronavirus Infections - drug therapy
Coronavirus Infections - virology
COVID-19
Drug Resistance, Microbial
Drug Utilization - statistics & numerical data
Hospitals
Humans
Pandemics
Pneumonia, Viral - drug therapy
Pneumonia, Viral - virology
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There are scant data on the impact of coronavirus disease 2019 (COVID-19) on hospital antibiotic consumption, and no data from outside epicenters. At our nonepicenter hospital, antibiotic days of therapy (DOT) and bed days of care (BDOC) were reduced by 151.5/month and 285/month, respectively, for March to June 2020 compared to 2018-2019 ( 0.001 and 0.001). DOT per 1,000 BDOC was increased (8.1/month; 0.001). COVID-19 will impact antibiotic consumption, stewardship, and resistance in ways that will likely differ temporally and by region.
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.01011-20